- Home
- ROIV vs SNV Comparison
ROIV vs SNV Comparison
Compare ROIV & SNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- SNV
- Stock Information
- Founded
- ROIV 2014
- SNV 1888
- Country
- ROIV United Kingdom
- SNV United States
- Employees
- ROIV N/A
- SNV N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- SNV Major Banks
- Sector
- ROIV Health Care
- SNV Finance
- Exchange
- ROIV Nasdaq
- SNV Nasdaq
- Market Cap
- ROIV 8.8B
- SNV 7.8B
- IPO Year
- ROIV N/A
- SNV N/A
- Fundamental
- Price
- ROIV $11.57
- SNV $50.29
- Analyst Decision
- ROIV Strong Buy
- SNV Buy
- Analyst Count
- ROIV 8
- SNV 19
- Target Price
- ROIV $17.93
- SNV $56.74
- AVG Volume (30 Days)
- ROIV 5.3M
- SNV 1.4M
- Earning Date
- ROIV 02-11-2025
- SNV 01-15-2025
- Dividend Yield
- ROIV N/A
- SNV 3.02%
- EPS Growth
- ROIV N/A
- SNV N/A
- EPS
- ROIV 5.89
- SNV 2.20
- Revenue
- ROIV $129,128,999.00
- SNV $1,750,692,000.00
- Revenue This Year
- ROIV $15.98
- SNV N/A
- Revenue Next Year
- ROIV N/A
- SNV $11.27
- P/E Ratio
- ROIV $2.06
- SNV $22.89
- Revenue Growth
- ROIV 145.68
- SNV N/A
- 52 Week Low
- ROIV $9.69
- SNV $33.44
- 52 Week High
- ROIV $13.06
- SNV $59.92
- Technical
- Relative Strength Index (RSI)
- ROIV 41.56
- SNV 35.36
- Support Level
- ROIV $11.72
- SNV $54.28
- Resistance Level
- ROIV $12.22
- SNV $57.12
- Average True Range (ATR)
- ROIV 0.30
- SNV 1.64
- MACD
- ROIV -0.09
- SNV -0.90
- Stochastic Oscillator
- ROIV 15.24
- SNV 13.45
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About SNV Synovus Financial Corp.
Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.